Briumvi 73150-0150-06
Generic: Ublituximab
- Manufacturer
- Tg Therapeutics, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 28, 2022
- Listing Expires
- December 31, 2027
- Application
- BLA761238
Need to source Briumvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ublituximab | 150 mg/6mL |
Drug Class
CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]
Selected Package
73150-0150-06Selected1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE